Home » Topics » BioWorld Science

BioWorld Science
RSS

Bromodomain inhibitors reported in Medshine Discovery patent

April 17, 2019

Biomica initiates preclinical studies in immuno-oncology program

April 17, 2019

Gilead and insitro enter strategic collaboration to discover and develop new therapies for NASH

April 17, 2019

Wave Life Sciences presents phase I data and updates on development of suvodirsen

April 17, 2019

IL-7 receptor plays role in severe IBD

April 17, 2019

New candidate drug for visceral leishmaniasis

April 17, 2019

Preventing drug tolerance to forestall resistance

April 17, 2019

Cortexyme launches phase II/III study of COR-388 in subjects with Alzheimer's disease

April 16, 2019

Interim results presented from phase II study of chikungunya virus vaccine candidate

April 16, 2019

Positive 12-month data presented from phase II study of Clascoterone

April 16, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...